Advertisement
Research ArticleChemotherapy, Antibiotics, and Gene Therapy

Activation of Alternate Pro-Survival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts

Qingyu Zhou, Hua Lv, Amin R Mazloom, Huilei Xu, Avi Ma'ayan and James M Gallo
Journal of Pharmacology and Experimental Therapeutics August 6, 2012, jpet.112.196097; DOI: https://doi.org/10.1124/jpet.112.196097
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleChemotherapy, Antibiotics, and Gene Therapy

Activation of Alternate Pro-Survival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts

Qingyu Zhou, Hua Lv, Amin R Mazloom, Huilei Xu, Avi Ma'ayan and James M Gallo
Journal of Pharmacology and Experimental Therapeutics August 6, 2012, jpet.112.196097; DOI: https://doi.org/10.1124/jpet.112.196097
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement